Nacolomab tafenatox

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Nacolomab tafenatox
Monoclonal antibody
Type Fab fragment
Source Mouse
Target colorectal tumor antigen C242
Clinical data
ATC code
  • none
CAS Number
  • none
 NYesY (what is this?)  (verify)

Nacolomab tafenatox is a mouse monoclonal antibody[1] designed for the treatment of colorectal cancer.[citation needed] The antibody itself, nacolomab, is fused with enterotoxin A from Staphylococcus aureus (which is reflected by 'tafenatox' in the drug's name).[1]

Schematic image of nacolomab tafenatox.
VH, VL: variable (antigen binding) domains of antibody fragment
CH1, CL: constant domains of antibody fragment
SAg: enterotoxin A (acting as a superantigen)

See also[edit]